Journal article
Endogenous peptide YY and neuropeptide y inhibit colonic ion transport, contractility and transit differentially via Y 1 and Y 2 receptors
IR Tough, S Forbes, R Tolhurst, M Ellis, H Herzog, JC Bornstein, HM Cox
British Journal of Pharmacology | Published : 2011
Abstract
BACKGROUND AND PURPOSE Peptide YY (PYY) and neuropeptide Y (NPY) activate Y receptors, targets under consideration as treatments for diarrhoea and other intestinal disorders. We investigated the gastrointestinal consequences of selective PYY or NPY ablation on mucosal ion transport, smooth muscle activity and transit using wild-type, single and double peptide knockout mice, comparing mucosal responses with those from human colon. EXPERIMENTAL APPROACH Mucosae were pretreated with a Y 1 (BIBO3304) or Y 2 (BIIE0246) receptor antagonist and changes in short-circuit current recorded. Colonic transit and colonic migrating motor complexes (CMMCs) were assessed in vitro and upper gastrointestinal a..
View full abstractGrants
Awarded by European Commission
Funding Acknowledgements
This research was funded by the Wellcome Trust (Grant ref; 079291/Z/06/Z, IRT, HMC), BBSRC (Integrative Biomedicine Initiative, SF, HMC), EU's 7th Framework Programme, Grant Agreement: no. 223057 (GIPIO; RT, HMC), a NHMRC of Australia Research Fellowship (# 427606, HH) and research grant (# 566642, ME, JCB).